AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Paradigm Biopharmaceuticals Limited

AUD 0.25 -$0.09 (-26.47%)
ASX · 16 Sep 2026 06:10 UTC
Previous Close
AUD 0.25
Day Range
AUD 0.24AUD 0.26
Year Range
AUD 0.14AUD 0.47
Market Cap
149.8M
AVG Volume
2.22M
Trailing/Forward PE
-1.64/-
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2027-02-24
Primary Exchange
Australian Securities ExchangeAU
Revenue (AUD)
020K40K60K80K22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Revenue (AUD) by quarter
PeriodRevenue (AUD)
26 Q455K
26 Q225.15K
25 Q435.42K
25 Q216.7K
24 Q465.8K
24 Q20
23 Q442.05K
23 Q24.71K
22 Q434.02K
22 Q245.2K
Net Income (AUD)
-60M-40M-20M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Net Income (AUD) by quarter
PeriodNet Income (AUD)
26 Q4-33.09M
26 Q2-23.24M
25 Q4-12.85M
25 Q2-5.92M
24 Q4-9.7M
24 Q2-48.96M
23 Q4-20.04M
23 Q2-31.87M
22 Q4-12.27M
22 Q2-26.98M
Operating Income (AUD)
-60M-40M-20M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Operating Income (AUD) by quarter
PeriodOperating Income (AUD)
26 Q4-39.28M
26 Q2-21.83M
25 Q4-16.8M
25 Q2-6.35M
24 Q4-14.97M
24 Q2-49.89M
23 Q4-26.92M
23 Q2-32.76M
22 Q4-19.75M
22 Q2-27.26M
EBITDA (AUD)
-60M-40M-20M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX EBITDA (AUD) by quarter
PeriodEBITDA (AUD)
26 Q4-39.2M
26 Q2-21.76M
25 Q4-18.97M
25 Q2-6.28M
24 Q4-14.89M
24 Q2-50.07M
23 Q4-26.22M
23 Q2-32.68M
22 Q4-20.16M
22 Q2-27.58M
Cash Flows (AUD)
-60M-40M-20M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Cash Flows (AUD) by quarter
PeriodCash Flows (AUD)
26 Q40
26 Q20
25 Q4-7.77M
25 Q2-8.22M
24 Q4-14.92M
24 Q2-51.02M
23 Q4-27.43M
23 Q2-17.75M
22 Q4-15.48M
22 Q2-16.73M
EPS (AUD)
-0.2-0.15-0.1-0.05-022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX EPS (AUD) by quarter
PeriodEPS (AUD)
26 Q4-0.1
26 Q2-0.06
25 Q4-0.03
25 Q2-0.02
24 Q4-0.03
24 Q2-0.17
23 Q4-0.07
23 Q2-0.12
22 Q4-0.05
22 Q2-0.11
Expenses (AUD)
-40M-20M020M40M60MR&DSG&ACapex22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Expenses (AUD) by quarter
PeriodExpenses (AUD)
26 Q415.21M
26 Q22.13M
25 Q416.76M
25 Q26.35M
24 Q434.24K
24 Q250.15M
23 Q426.87M
23 Q232.22M
22 Q419.62M
22 Q227.13M
Cash & Debt (AUD)
025M50M75M100MCashLong Term DebtShort Term Debt22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Cash & Debt (AUD) by quarter
PeriodCash & Debt (AUD)
26 Q415.44M
26 Q214.66M
25 Q416.82M
25 Q224.78M
24 Q417.87M
24 Q233.55M
23 Q456.38M
23 Q283.93M
22 Q439.72M
22 Q255.03M
Debt ratios
00.250.50.75122 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Debt ratios by quarter
PeriodDebt ratios
26 Q40.09
26 Q20.22
25 Q40.19
25 Q20.25
24 Q40.14
24 Q20.26
23 Q40.53
23 Q20.89
22 Q40.48
22 Q20.74
Margins
-2000%-1500%-1000%-500%0%500%21 Q422 Q222 Q423 Q223 Q424 Q425 Q225 Q426 Q226 Q4
PAR.AX Margins by quarter
PeriodMargins
26 Q4-56.72%
26 Q2-203.46%
25 Q4-131.01%
25 Q2-12.07%
24 Q4197.89%
23 Q4-38.47%
23 Q2-1688.98%
22 Q4-396.78%
22 Q2-269.91%
21 Q4-900.24%
Return on Capital
-1000%-750%-500%-250%0%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Return on Capital by quarter
PeriodReturn on Capital
26 Q4-953.31%
26 Q2-387.56%
25 Q4-60.64%
25 Q2-17.4%
24 Q4-40.72%
24 Q2-144.85%
23 Q4-37.34%
23 Q2-43.26%
22 Q4-28.99%
22 Q2-50.99%
Shares Outstanding
0200M400M600M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Shares Outstanding by quarter
PeriodShares Outstanding
26 Q4344.43M
26 Q2413.83M
25 Q4389.43M
25 Q2354.05M
24 Q4286.6M
24 Q2299.79M
23 Q4289.68M
23 Q2269.21M
22 Q4240.96M
22 Q2239.51M
Book Value Per Share (AUD)
00.10.20.322 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Book Value Per Share (AUD) by quarter
PeriodBook Value Per Share (AUD)
26 Q40.01
26 Q20.01
25 Q40.05
25 Q20.1
24 Q40.08
24 Q20.11
23 Q40.19
23 Q20.27
22 Q40.18
22 Q20.22
Total Assets (AUD)
025M50M75M100M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
PAR.AX Total Assets (AUD) by quarter
PeriodTotal Assets (AUD)
26 Q430.55M
26 Q223.15M
25 Q424.57M
25 Q235.36M
24 Q427.39M
24 Q245.04M
23 Q467.07M
23 Q288.5M
22 Q450.69M
22 Q267.49M
Free Cash Flow Yield
-200%-150%-100%-50%0%med -69.64%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PAR.AX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-29.88%
Sep 26-31.13%
Sep 26-28.19%
Aug 26-35.57%
Aug 26-42.69%
Aug 26-41.5%
Aug 26-42.69%
Jul 26-45.28%
Jul 26-45.28%
Jul 26-43.94%
Jul 26-43.94%
Jul 26-42.69%
Jun 26-48.2%
Jun 26-43.94%
Jun 26-49.8%
Jun 26-51.52%
May 26-45.28%
May 26-43.94%
May 26-43.94%
May 26-40.38%
May 26-46.69%
Apr 26-33.2%
Apr 26-33.2%
Apr 26-32.48%
Apr 26-28.73%
Mar 26-80.93%
Mar 26-82.51%
Mar 26-80.93%
Mar 26-82.51%
Feb 26-80.93%
Feb 26-75.14%
Feb 26-70.14%
Feb 26-72.55%
Jan 26-68.99%
Jan 26-64.74%
Jan 26-62.81%
Jan 26-60.99%
Jan 26-61.88%
Dec 25-61.88%
Dec 25-65.75%
Dec 25-66.8%
Dec 25-58.45%
Nov 25-54.65%
Nov 25-68.99%
Nov 25-61.88%
Nov 25-56.87%
Oct 25-49.51%
Oct 25-48.37%
Oct 25-52.6%
Oct 25-55.37%
Oct 25-59.27%
Sep 25-95.65%
Sep 25-97.27%
Sep 25-106.28%
Sep 25-102.48%
Aug 25-97.27%
Aug 25-92.57%
Aug 25-85.66%
Aug 25-91.1%
Aug 25-83.18%
Jul 25-66.73%
Jul 25-68.32%
Jul 25-69.15%
Jul 25-61.71%
Jun 25-89.67%
Jun 25-95.65%
Jun 25-98.95%
Jun 25-100.69%
May 25-89.67%
May 25-91.1%
May 25-86.96%
May 25-91.1%
May 25-92.57%
Apr 25-95.65%
Apr 25-98.95%
Apr 25-98.95%
Apr 25-95.65%
Mar 25-117.5%
Mar 25-92.32%
Mar 25-92.32%
Mar 25-81.63%
Feb 25-79.13%
Feb 25-63.05%
Feb 25-75.29%
Feb 25-77.55%
Jan 25-66.28%
Jan 25-82.5%
Jan 25-85.22%
Jan 25-92.32%
Jan 25-94.58%
Dec 24-99.43%
Dec 24-103.4%
Dec 24-102.04%
Dec 24-66.85%
Nov 24-75.29%
Nov 24-119.31%
Nov 24-161.57%
Nov 24-172.34%
Nov 24-189.15%
Oct 24-184.65%
Price to Sales
0500100015002000med 888.31Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PAR.AX Price to Sales by quarter
PeriodPrice to Sales
Sep 26723.12
Sep 26694.2
Sep 26766.51
Aug 26607.42
Aug 26506.19
Aug 26520.65
Aug 26506.19
Jul 26477.26
Jul 26477.26
Jul 26491.72
Jul 26491.72
Jul 26506.19
Jun 26448.34
Jun 26491.72
Jun 26433.87
Jun 26419.41
May 26477.26
May 26491.72
May 26491.72
May 26535.11
May 26462.8
Apr 26650.81
Apr 26650.81
Apr 26665.27
Apr 26752.05
Mar 26858.65
Mar 26842.13
Mar 26858.65
Mar 26842.13
Feb 26858.65
Feb 26924.7
Feb 26990.74
Feb 26957.72
Jan 261007.26
Jan 261073.31
Jan 261106.33
Jan 261139.36
Jan 261122.84
Dec 251122.84
Dec 251056.79
Dec 251040.28
Dec 251188.89
Nov 251271.46
Nov 251007.26
Nov 251122.84
Nov 251221.92
Oct 251403.56
Oct 251436.58
Oct 251320.99
Oct 251254.94
Oct 251172.38
Sep 25852.78
Sep 25838.57
Sep 25767.5
Sep 25795.93
Aug 25838.57
Aug 25881.21
Aug 25952.27
Aug 25895.42
Aug 25980.7
Jul 251222.32
Jul 251193.89
Jul 251179.68
Jul 251321.81
Jun 25909.63
Jun 25852.78
Jun 25824.35
Jun 25810.14
May 25909.63
May 25895.42
May 25938.06
May 25895.42
May 25881.21
Apr 25852.78
Apr 25824.35
Apr 25824.35
Apr 25852.78
Mar 25840.24
Mar 251069.4
Mar 251069.4
Mar 251209.44
Feb 251247.63
Feb 251565.91
Feb 251311.29
Feb 251273.09
Jan 251489.52
Jan 251196.71
Jan 251158.52
Jan 251069.4
Jan 251043.94
Dec 24993.01
Dec 24954.82
Dec 24967.55
Dec 241476.79
Nov 241311.29
Nov 24827.51
Nov 24611.09
Nov 24572.89
Nov 24521.97
Oct 24534.7
EV/EBITDA
16001800200022002400med 1981.4Oct 15Nov 15Dec 15Dec 15Jan 16Feb 16Mar 16
PAR.AX EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 161948.78
Mar 162143.06
Mar 162013.54
Mar 161884.09
Feb 161819.33
Feb 161689.81
Feb 161949.26
Feb 161949.26
Jan 161948.78
Jan 162078.78
Jan 162078.78
Jan 162143.54
Dec 152143.06
Dec 152143.54
Dec 152014.02
Dec 152207.82
Dec 152013.54
Nov 152013.54
Nov 152143.06
Nov 152078.3
Nov 151819.74
Oct 151819.74
Oct 151949.26
Oct 151948.78
Oct 151948.78
Oct 151949.26
Price to Book
05101520med 5.63Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
PAR.AX Price to Book by quarter
PeriodPrice to Book
Sep 2617.25
Sep 2616.56
Sep 2618.28
Aug 2614.49
Aug 2612.07
Aug 2612.42
Aug 2612.07
Jul 2611.38
Jul 2611.38
Jul 2611.73
Jul 2611.73
Jul 2612.07
Jun 2610.69
Jun 2611.73
Jun 2610.35
Jun 2610
May 2611.38
May 2611.73
May 2611.73
May 2612.76
May 2611.04
Apr 2615.52
Apr 2615.52
Apr 2615.87
Apr 2617.94
Mar 264.78
Mar 264.69
Mar 264.78
Mar 264.69
Feb 264.78
Feb 265.15
Feb 265.51
Feb 265.33
Jan 265.61
Jan 265.97
Jan 266.16
Jan 266.34
Jan 266.25
Dec 256.25
Dec 255.88
Dec 255.79
Dec 256.62
Nov 257.08
Nov 255.61
Nov 256.25
Nov 256.8
Oct 257.81
Oct 258
Oct 257.35
Oct 256.99
Oct 256.53
Sep 253.12
Sep 253.07
Sep 252.81
Sep 252.91
Aug 253.07
Aug 253.22
Aug 253.48
Aug 253.27
Aug 253.59
Jul 254.47
Jul 254.37
Jul 254.31
Jul 254.83
Jun 253.33
Jun 253.12
Jun 253.01
Jun 252.96
May 253.33
May 253.27
May 253.43
May 253.27
May 253.22
Apr 253.12
Apr 253.01
Apr 253.01
Apr 253.12
Mar 253.97
Mar 255.06
Mar 255.06
Mar 255.72
Feb 255.9
Feb 257.4
Feb 256.2
Feb 256.02
Jan 257.04
Jan 255.66
Jan 255.48
Jan 255.06
Jan 254.94
Dec 244.7
Dec 244.51
Dec 244.57
Dec 246.98
Nov 246.2
Nov 243.91
Nov 242.89
Nov 242.71
Nov 242.47
Oct 242.53
Paradigm Biopharmaceuticals Limited
PAR.AX
Stockpicker

Video analysis: PAR.AX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.